Bailard Inc. bought a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 31,747 shares of the company’s stock, valued at approximately $255,000. Bailard Inc. owned about 0.08% of Viemed Healthcare at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. GSA Capital Partners LLP boosted its position in shares of Viemed Healthcare by 37.1% during the third quarter. GSA Capital Partners LLP now owns 17,836 shares of the company’s stock valued at $131,000 after buying an additional 4,829 shares during the last quarter. Victory Capital Management Inc. lifted its stake in Viemed Healthcare by 748.2% during the 3rd quarter. Victory Capital Management Inc. now owns 108,497 shares of the company’s stock valued at $795,000 after acquiring an additional 95,706 shares during the period. Oppenheimer Asset Management Inc. boosted its holdings in shares of Viemed Healthcare by 5.6% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 30,222 shares of the company’s stock valued at $222,000 after acquiring an additional 1,601 shares during the last quarter. Bard Associates Inc. grew its stake in shares of Viemed Healthcare by 1.1% in the third quarter. Bard Associates Inc. now owns 345,052 shares of the company’s stock worth $2,529,000 after acquiring an additional 3,762 shares during the period. Finally, Thrivent Financial for Lutherans raised its holdings in shares of Viemed Healthcare by 0.6% during the third quarter. Thrivent Financial for Lutherans now owns 3,425,693 shares of the company’s stock valued at $25,110,000 after purchasing an additional 21,047 shares during the last quarter. Institutional investors own 74.24% of the company’s stock.
Viemed Healthcare Trading Down 1.2 %
Shares of VMD stock opened at $7.52 on Thursday. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a 12-month low of $6.21 and a 12-month high of $10.44. The stock has a market capitalization of $292.81 million, a P/E ratio of 27.85 and a beta of 1.45. The firm’s 50 day moving average is $8.04 and its 200 day moving average is $8.19.
Viemed Healthcare Company Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Further Reading
- Five stocks we like better than Viemed Healthcare
- The 3 Best Fintech Stocks to Buy Now
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Investing in Commodities: What Are They? How to Invest in Them
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- What is the S&P/TSX Index?
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.